Table 4.
Secondary outcomes (intraoperative and postoperative data)
| Group S (n=41) | Group T (n=41) | Group C (n=41) | P-Value | |
|---|---|---|---|---|
| Intraoperative total dose of remifentanil (μg) | 963.6±302.7 | 989.3±310.6 | 977.2±313.7 | 0.63 |
| Duration of stay in PACU (min) | 48±12.3 | 50±13.1 | 46±12.6 | 0.51 |
| PONV | 8 (19.5%) | 9 (22.0%) | 15 (36.6%) | 0.163 |
| Excessive sedation | 0 (0%) | 1 (2.4%) | 1 (2.4%) | 1.0 |
| Urinary retention | 1 (2.4%) | 0 (0%) | 1 (2.4%) | 1.0 |
| Hypotension | 0 (0%) | 3 (7.3%) | 1 (2.4%) | 0.32 |
| Chest tube indwelling time (h) | 55.8 (42.1–79.6) | 50.6 (39.8–82.3) | 52.3 (41.3–87.6) | 0.26 |
| Length of hospital stay (d) | 6.07±1.86 | 6.65±2.3 | 6.92±2.2 | 0.16 |